Design and Characterization of Paclitaxel Loaded Nanoparticles with Piperine
Abstract
Paclitaxel is a cytotoxic drug having wonderful mechanism against cancer cells. However, it showed severe dose-limiting toxicity when administered as infusion. To overcome these side effects a suitable delivery system is highly desirable. Bioenhancers, when mixed with drugs promote and augment their bioavailability and reduced incidence of drug resistance and risk of adverse drug reaction. Therefore, based on the literature survey nanoparticles are selected as a delivery system in this study. The object of this work was to entrap paclitaxel and herbal bioenhancer in a nanoparticle system. In that work the nanoparticles prepared the by emulsion solvent evaporation method with Eudragit RLPO1 polymer. The prepared nanoparticles were evaluated for particle size, zeta potential, drug entrapment, in vitro drug release. Further the nanoparticles were evaluated for in vitro cell cytotoxicity study by mean transit time (MTT) assay on lung cancer cell line and pharmacokinetic profile. The bioenhancer loaded nanoparticles show betrer in-vitro properties with 124 to 200 nm particle size range. All the formulations released within the range of 82.71 to 95.47% of drug in 24 hours. The release kinetic of drug was best fitted to Higuchi’s model and was following Fick’s law of diffusion. All the nanoparticle batches had good drug entrapment capacity in the range of 57.51 to 86.12%. The pure drug solution could not inhibit the cell proliferation completely but the nanoparticle formulations significantly reduced the cell proliferation in MTT assay. Surprisingly, formulation with higher bioenhancer loading (FNP 6) showed a higher antiproliferative effect on A549 cells. In in vivo pharmacokinetic assay, the plasma level of FNP-6 was highest than other formulation including control. The AUC of FNP-6 was 6.423 μg/mL and the absolute bioavailability of FNP-6 was 7.89. FNP-5 and FNP-6 had a higher bioenhancer quantity as compare to the other formulation this may be possible reason of their higher absolute bioavailability. Therefore, it can be concluded that addition of bioenhancer with antitumor drug can enhance its proliferative effect and bioavailability.
Keywords:
Anti-cancer, Bioenhancer, ERLPO, Nanoparticle, Paclitaxel, Piperine.DOI
https://doi.org/10.25004/IJPSDR.2022.140213References
DB M, S S, KR M. Role of Piperine as an Effective Bioenhancer in Drug Absorption. Pharm Anal Acta [Internet]. 2018 [cited 2021 Jun 24];09(07):7–10.
Gottesman MM, Pastan IH. The Role of Multidrug Resistance Efflux Pumps in Cancer: Revisiting a JNCI Publication Exploring Expression of the MDR1 (P-glycoprotein) Gene [Internet]. Vol. 107, Journal of the National Cancer Institute. Oxford University Press; 2015 [cited 2021 Jun 24].
Key A, Sch T, Pharm AJ, Verma S, Rai S. Scholars Academic Journal of Pharmacy ( SAJP ) Bioenhancers from Mother Nature : A Paradigm for Modern Medicines. 2018;
Ramalingam S, Belani CP. Paclitaxel for non-small cell lung cancer. Expert Opin Pharmacother. 2004;5(8):1771–80.
Das S, Suresh PK, Desmuk h R . Design of Eudragit RL 100 nanoparticles by nanoprecipitation method for ocular drug delivery. Nanomedicine Nanotechnology, Biol Med [Internet]. 2010;6(2):318–23.
Yang W, Xia Y, Fang Y, Meng F, Zhang J, Cheng R, et al. Selective Cell Penetrating Peptide-Functionalized Polymersomes Mediate Efficient and Targeted Delivery of Methotrexate Disodium to Human Lung Cancer In Vivo. Adv Healthc Mater. 2018;7(7):1–8.
Bhardwaj RK, Glaeser H, Becquemont L, Klotz U, Gupta SK, Fromm MF. Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. J Pharmacol Exp Ther. 2002;302(2):645–50.
Pradeep CR, Kuttan G. Piperine is a potent inhibitor of nuclear factor-κB (NF-κB), c-Fos, CREB, ATF-2 and proinflammatory c y tok ine gene expression in B16F-10 melanoma cells. Int Immunopharmacol. 2004;4(14 SPEC.ISS.):1795–803.
Greenshields AL, Doucette CD, Sutton KM, Madera L, Annan H, Yaffe PB, et al. Piperine inhibits the growth and motility of triple-negative breast cancer cells. Cancer Lett [Internet]. 2015;357(1):129–40.
Selvendiran K, Prince Vijeya Singh J, Sakthisekaran D. In vivo effect of piperine on serum and tissue glycoprotein levels in benzo(a)pyrene induced lung carcinogenesis in Swiss albino mice. Pulm Pharmacol Ther [Internet]. 2006 Apr 21 [cited 2021 Jun 29];19(2):107–11.
Volak LP, Ghirmai S, Cashman JR, Court MH. Curcuminoids inhibit multiple human cytochromes P450, UDP- glucuronosyltransferase, and sulfotransferase enzymes, whereas piperine is a relatively selective CYP3A4 inhibitor. Drug Metab Dispos. 2008;36(8):1594– 605.
Motiwala MN, Rangari VD. ScienceDirect Combined effect of paclitaxel and piperine on a MCF-7 breast cancer cell line in vitro : Evidence of a synergistic interaction. Synergy [Internet]. 2015;2(1):1–6.
Pandita D, Ahuja A, Velpandian T, Lather V, Dut ta T, K har RK. Characterization and in vitro assessment of paclitaxel loaded lipid nanoparticles formulated using modified solvent injection technique. Pharmazie [Internet]. 2009 [cited 2021 Jun 29];64(5):301–10.
Gandhi A, Jana S, Sen KK. In-vitro release of acyclovir loaded Eudragit RLPO® nanoparticles for sustained drug delivery. Int J Biol Macromol [Internet]. 2014 Jun 1 [cited 2021 Jun 22];67:478–82.
Hoa LTM, Chi NT, Nguyen LH, Chien DM. Preparation and characterisation of nanoparticles containing ketoprofen and acrylic polymers prepared by emulsion solvent evaporation method. J Exp Nanosci [Internet]. 2012 Mar [cited 2021 Jun 23];7(2):189–97. https://www.tandfonline.com/action/journalInformation?journ alCode=tjen20
Deshmukh R, Harwansh RK, Paul S Das, Shukla R. Controlled release of sulfasalazine loaded amidated pectin microparticles through Eudragit S 100 coated capsule for management of inflammatory bowel disease. J Drug Deliv Sci Technol. 2020;55:101495.
Published
Abstract Display: 527 
PDF Downloads: 519 
